Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 72.18M P/E - EPS this Y -275.00% Ern Qtrly Grth -
Income -6.69M Forward P/E 31.44 EPS next Y 273.30% 50D Avg Chg -18.00%
Sales 31.38M PEG - EPS past 5Y - 200D Avg Chg -16.00%
Dividend N/A Price/Book 6.42 EPS next 5Y - 52W High Chg -34.00%
Recommedations 2.00 Quick Ratio 1.24 Shares Outstanding 25.84M 52W Low Chg 45.00%
Insider Own 5.39% ROA -12.50% Shares Float 21.76M Beta 1.30
Inst Own 33.13% ROE -44.30% Shares Shorted/Prior 75.49K/69.64K Price 2.83
Gross Margin 59.48% Profit Margin -21.31% Avg. Volume 54,980 Target Price 8.50
Oper. Margin -32.35% Earnings Date Aug 8 Volume 8,456 Change 0.35%
About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Eton Pharmaceuticals, Inc. News
11/15/24 Eton Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
11/13/24 Q3 2024 Eton Pharmaceuticals Inc Earnings Call
11/13/24 Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...
11/12/24 Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
11/07/24 Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
11/06/24 Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
10/29/24 Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum
10/17/24 SWK Holdings Provides Portfolio Update
10/14/24 Analysts Expect Breakeven For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Before Long
10/03/24 Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
09/13/24 Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc.
08/22/24 Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
08/11/24 Eton Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
08/08/24 Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
08/02/24 Shareholders in Eton Pharmaceuticals (NASDAQ:ETON) are in the red if they invested five years ago
07/30/24 Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
07/17/24 SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
07/15/24 Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
06/22/24 Are Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
05/12/24 Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations
ETON Chatroom

User Image Luella_Salinas Posted - 23 hours ago

$CRBP $ETON $FULC LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

User Image OracleofOntario Posted - 2 days ago

$ETON Recent ER call: "Thirdly, reaching a $1 billion market cap. If we’re successful in delivering on our strategy on these first two goals and developing and launching new products and continuing to execute value-creating acquisitions we believe we can reach this milestone in the coming years."

User Image OracleofOntario Posted - 5 days ago

$ETON what's causing the big drop this morning?

User Image dannymac65 Posted - 6 days ago

$ETON The 3 month chart is why I love stonks.

User Image SpyVsSpy2 Posted - 1 week ago

$ETON

User Image bryantboy99 Posted - 1 week ago

$AUPH this is boring. Thank goodness for $ETON lol

User Image bryantboy99 Posted - 1 week ago

$ETON imagine there has to be institutions loading here after the earnings call yesterday.

User Image Hustle55 Posted - 1 week ago

$ETON

User Image oaksapollo Posted - 1 week ago

$ETON holy crap. Somebody liked what they heard on the call yesterday!

User Image Happy_Feet19 Posted - 1 week ago

$ETON CEO states his near term goal of a market cap of $1 Billion is achievable. That's is a $40 per share goal. Great!

User Image Doozio Posted - 1 week ago

Keep on $Eton these huckleberry rides INTA 🧠⏰♾️

User Image badgermobile Posted - 1 week ago

$ETON ok Congrats and Good Luck. We have a new drug getting approved in February why leave this should double by mid year

User Image DonCorleone77 Posted - 1 week ago

$ETON Eton Pharmaceuticals reports Q3 EPS 2c, consensus (1c) Reports Q3 revenue $10.32M, consensus $9.69M. "Our strong product revenue growth in the third quarter allowed us to achieve positive GAAP net income from product revenue for the first time in the Company's history and we're pleased to reach this important milestone one quarter ahead of our original goal. We are proud of our ability to continue delivering exceptional growth, as demonstrated by our 15th straight quarter of sequential growth in product revenue, while managing the bottom line," said Sean Brynjelsen, CEO of Eton Pharmaceuticals.

User Image bryantboy99 Posted - 1 week ago

$ETON looks like another strong quarter. Running on all cylinders

User Image TwongStocks Posted - 1 week ago

$ETON Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-reports-third-quarter-2024-financial -Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted share -Entered into an asset purchase agreement to acquire Increlex® (mecasermin injection) -Q3 2024 product sales increased 40% over Q3 2023, representing 15th straight quarter of sequential product sales growth -Produced positive quarterly GAAP net income from product sales for first time in company history -Generated cash from operations of $2.9 million in Q3 2024 -Granted additional patent for ET-400 -Management to hold conference call today at 4:30pm ET

User Image CFontina Posted - 1 week ago

$ETON I've done great on this company, having owned about 20k shares at $3, but it ain't worth more than $250m EV at this point. Still holding a few thousand just in case, but mostly out now. Good luck. Been a great run.

User Image bryantboy99 Posted - 1 week ago

$ETON October investor presentation in case anyone would like to review. Future looks really bright here with the Increlex acquisition and ET-400 PDUFA date of 2/28/2025. Think I'll hold on to my shares. https://ir.etonpharma.com/static-files/0f086a1d-e0ea-4b95-98f7-400e06be7182

User Image Roaring_Immu Posted - 1 week ago

$ETON I am expecting earnings and guidance would be blockbuster...taking the price to new heights that we haven't seen in a while

User Image Roaring_Immu Posted - 1 week ago

$ETON fantabulous run without being noticed by paper hands...3.5 to 10 wooohoo

User Image bryantboy99 Posted - 1 week ago

$ETON what a run. How much higher can it go?

User Image SpyVsSpy2 Posted - 1 week ago

$ETON following the path of $HROW

User Image RunsWithDogs Posted - 1 week ago

$ETON I haven't posted in a month, so here are a few random thoughts: Seems to me some big analyst firms are buying large blocks of shares and betting on good earnings. Hopefully, they keep doing it quietly tomorrow. Even with volume over 500k a day, it hasn't hit retails radar because there are better gains in other visible companies and sectors. Not even my biggest winner of the day and I didn't notice until it moved above $9.50. Options are a bit more liquid so I picked up a few $7.5 calls to exercise near the end of the year, assuming Q3 earnings are good. GLTA

User Image EdwardTeach Posted - 1 week ago

$ETON should go beyond $10....glta

User Image EdwardTeach Posted - 1 week ago

$ETON https://finance.yahoo.com/news/expect-eton-pharmaceuticals-inc-eton-121837867.html

User Image bryantboy99 Posted - 1 week ago

$ETON liftoff?

User Image Preston_Carr Posted - 1 week ago

MYNZ 🔥 Perfect time to jump in, cheapest dip!!! Shorts volume increased. Low Float only 29M outstanding shares. Any buy-in will make this fly to the moon. Here is why… 1.Frankie Muniz backing Mainz (yes, the Malcolm guy & NASCAR #33 now repping MYNZ). 2.Petra, ex-Obama advisor, hinted at a big U.S. lab partner. Solid source! 3.Six news hits in 3 weeks—momentum. 4.Already solid in the EU, not new but expanding, with insurance covering their tests. 5.Their test has 88% accuracy vs. EXAS (42%) & GH (20%)—big edge! 6.$1.5M private placement in the bag. 7.CEO teased big plans ahead. 8.Offering Deal $ETON $FULC

User Image PenkeTrading Posted - 1 week ago

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Eton Pharmaceuticals Inc. Is that bullish or bearish? $ETON #Eton #RsiOverbought #NASDAQ

User Image OracleofOntario Posted - 1 week ago

$ETON even after the recent Gaines the market cap is still at a ridiculously low $224M - many companies with far less potential have one twice this amount

User Image BioTuesdays Posted - 1 week ago

Eton Pharmaceuticals announced that the U.S. Patent and Trademark Office (USPTO) has granted the company a patent for its proprietary liquid hydrocortisone, ET-400 $ETON https://biotuesdays.com/2024/11/07/uspto-grants-second-patent-for-etons-et-400/

User Image EdwardTeach Posted - 1 week ago

$ETON is going to go to new heights...load the boat....glta

Analyst Ratings
Craig-Hallum Buy May 6, 24
HC Wainwright & Co. Buy Dec 11, 23
HC Wainwright & Co. Buy Aug 11, 23
HC Wainwright & Co. Buy Jul 3, 23
HC Wainwright & Co. Buy Mar 21, 23
HC Wainwright & Co. Buy Sep 26, 22
HC Wainwright & Co. Buy Jul 25, 22
HC Wainwright & Co. Buy Mar 22, 22
HC Wainwright & Co. Buy Mar 17, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
BRYNJELSEN SEAN Chief Executive Offi.. Chief Executive Officer Sep 22 Buy 2.1042 10,000 21,042 1,040,000 09/23/22
Opaleye Management Inc. 10% Owner 10% Owner Aug 06 Sell 5.81 604,500 3,512,145 117,100 08/06/21